Roche announced that it has received CE mark for its Elecsys Dengue Ag test – a high-throughput, fully automated immunoassay to be used as an aid in the… read more.
Takeda announced the completion of the 7-year pivotal Phase III Tetravalent Immunization against Dengue Efficacy Study (TIDES) trial evaluating its dengue vaccine, Qdenga (Dengue Tetravalent Vaccine [Live, Attenuated])… read more.
Bavarian Nordic A/S announced the award of a joint procurement contract by the European Commission, through the Health Emergency Preparedness and Response Authority (HERA), enabling the EU, its… read more.
Moderna, Inc. (announced data regarding two of its investigational influenza candidates will be presented at IDWeek 2025, October 19-22, 2025, in Atlanta, GA. The details of the presentations… read more.
Gilead Sciences, Inc. will present new findings from its antiviral research and development programs at IDWeek, taking place October 19-22 in Atlanta, GA. Data from 34 presentations across HIV,… read more.
Children and adolescents are at a significantly higher risk of various SARS-CoV-2 infection (PASC/long COVID) outcomes after reinfection with SARS-CoV-2, researchers reported in Lancet Infectious Diseases on September… read more.
Millions of people around the world are suffering with the serious cardiovascular effects of Covid infection and long Covid. A lack of clear guidance on how to reduce… read more.
UC Davis infectious diseases experts George Thompson and Angel Desai are raising the alarm about the role new pesticides can play in building resistance to antifungal medical treatments. In a commentary in the New England… read more.
In the hunt for a remedy, when the baton is passed from dedicated academic scientists to an innovative company to trusted community advocates, outcomes for society can be… read more.
A multi-state study reveals that many high-risk adults diagnosed with influenza (flu) in emergency departments and urgent care centers are not receiving timely antiviral treatment. Researchers found that… read more.
Amid a global surge in measles cases, new research suggests that undernutrition may be exacerbating outbreaks in areas suffering from food insecurity. A study involving over 600 fully… read more.
A year after becoming available, vaccines to protect against RSV in newborns and older adults are being more widely accepted by the American public, according to a new… read more.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.
